Cargando…

Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery

BACKGROUND: There are also differences in survival prognosis among esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after Neoadjuvant chemoradiotherapy (NCRT) followed by surgery. And the purpose of this study was to investigate influencing fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Min, Shen, Jianfei, Zhou, Chao, Yang, Haihua, Chen, Baofu, Zhu, Chengchu, Wang, Gongchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576096/
https://www.ncbi.nlm.nih.gov/pubmed/33240978
http://dx.doi.org/10.21037/atm-20-4864
_version_ 1783597946455982080
author Kong, Min
Shen, Jianfei
Zhou, Chao
Yang, Haihua
Chen, Baofu
Zhu, Chengchu
Wang, Gongchao
author_facet Kong, Min
Shen, Jianfei
Zhou, Chao
Yang, Haihua
Chen, Baofu
Zhu, Chengchu
Wang, Gongchao
author_sort Kong, Min
collection PubMed
description BACKGROUND: There are also differences in survival prognosis among esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after Neoadjuvant chemoradiotherapy (NCRT) followed by surgery. And the purpose of this study was to investigate influencing factors from these different prognostic outcomes and their possible causes. METHODS: The clinical data of 88 cases of ESCC patients with ypT0 after NCRT followed by surgery between 2011 and 2019 were retrospectively analyzed. The clinical and pathological prognostic factors that affect the survival were analyzed. RESULTS: Sex, number of lymph nodes dissected, and pathologic positivity of lymph nodes may be significant in univariate analysis (P<0.1). Further multivariate analysis suggested that the pathologic positivity of the lymph nodes was an independent factor affecting prognosis (HR: 4.757, 95% CI: 2.195–10.313, P=0.000). Subsequently, the whole group was divided into a positive lymph node group (group LN+) and a negative lymph node group (group LN−) for comparison. The overall survival (OS) of group LN+ was significantly worse (HR: 0.211, 95% CI: 0.0336–0.239; P<0.0001), and recurrence-free survival (RFS) was significantly poorer in the LN+ group (HR: 0.0679, 95% CI: 0.0239–0.1923, P<0.0001). There were 14 cases of recurrence and metastasis in the LN+ group (14/21, 66.7%) and 10 cases in the group LN− (10/67, 14.9%). Among the sites of recurrence and metastasis, there were 10 (10/14, 71.4%) and 4 (4/14, 28.6%) cases of distant metastasis, respectively, and 4 (4/14, 28.6%) cases of local metastasis in the LN+ group; meanwhile, there were 8 (8/10, 80.0%) cases of distant metastasis and 2 (2/10, 20.0%) cases of local metastasis in the LN− group. CONCLUSIONS: The independent risk factor for survival prognosis in ESCC patients with ypT0 after NCRT followed by surgery was positive postoperative pathological lymph nodes. The reason for the shortened survival time associated with this group of patients was their susceptibility to recurrence and metastasis.
format Online
Article
Text
id pubmed-7576096
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-75760962020-11-24 Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery Kong, Min Shen, Jianfei Zhou, Chao Yang, Haihua Chen, Baofu Zhu, Chengchu Wang, Gongchao Ann Transl Med Original Article BACKGROUND: There are also differences in survival prognosis among esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after Neoadjuvant chemoradiotherapy (NCRT) followed by surgery. And the purpose of this study was to investigate influencing factors from these different prognostic outcomes and their possible causes. METHODS: The clinical data of 88 cases of ESCC patients with ypT0 after NCRT followed by surgery between 2011 and 2019 were retrospectively analyzed. The clinical and pathological prognostic factors that affect the survival were analyzed. RESULTS: Sex, number of lymph nodes dissected, and pathologic positivity of lymph nodes may be significant in univariate analysis (P<0.1). Further multivariate analysis suggested that the pathologic positivity of the lymph nodes was an independent factor affecting prognosis (HR: 4.757, 95% CI: 2.195–10.313, P=0.000). Subsequently, the whole group was divided into a positive lymph node group (group LN+) and a negative lymph node group (group LN−) for comparison. The overall survival (OS) of group LN+ was significantly worse (HR: 0.211, 95% CI: 0.0336–0.239; P<0.0001), and recurrence-free survival (RFS) was significantly poorer in the LN+ group (HR: 0.0679, 95% CI: 0.0239–0.1923, P<0.0001). There were 14 cases of recurrence and metastasis in the LN+ group (14/21, 66.7%) and 10 cases in the group LN− (10/67, 14.9%). Among the sites of recurrence and metastasis, there were 10 (10/14, 71.4%) and 4 (4/14, 28.6%) cases of distant metastasis, respectively, and 4 (4/14, 28.6%) cases of local metastasis in the LN+ group; meanwhile, there were 8 (8/10, 80.0%) cases of distant metastasis and 2 (2/10, 20.0%) cases of local metastasis in the LN− group. CONCLUSIONS: The independent risk factor for survival prognosis in ESCC patients with ypT0 after NCRT followed by surgery was positive postoperative pathological lymph nodes. The reason for the shortened survival time associated with this group of patients was their susceptibility to recurrence and metastasis. AME Publishing Company 2020-09 /pmc/articles/PMC7576096/ /pubmed/33240978 http://dx.doi.org/10.21037/atm-20-4864 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Kong, Min
Shen, Jianfei
Zhou, Chao
Yang, Haihua
Chen, Baofu
Zhu, Chengchu
Wang, Gongchao
Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery
title Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery
title_full Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery
title_fullStr Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery
title_full_unstemmed Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery
title_short Prognostic factors for survival in esophageal squamous cell carcinoma (ESCC) patients with a complete regression of the primary tumor (ypT0) after neoadjuvant chemoradiotherapy (NCRT) followed by surgery
title_sort prognostic factors for survival in esophageal squamous cell carcinoma (escc) patients with a complete regression of the primary tumor (ypt0) after neoadjuvant chemoradiotherapy (ncrt) followed by surgery
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576096/
https://www.ncbi.nlm.nih.gov/pubmed/33240978
http://dx.doi.org/10.21037/atm-20-4864
work_keys_str_mv AT kongmin prognosticfactorsforsurvivalinesophagealsquamouscellcarcinomaesccpatientswithacompleteregressionoftheprimarytumorypt0afterneoadjuvantchemoradiotherapyncrtfollowedbysurgery
AT shenjianfei prognosticfactorsforsurvivalinesophagealsquamouscellcarcinomaesccpatientswithacompleteregressionoftheprimarytumorypt0afterneoadjuvantchemoradiotherapyncrtfollowedbysurgery
AT zhouchao prognosticfactorsforsurvivalinesophagealsquamouscellcarcinomaesccpatientswithacompleteregressionoftheprimarytumorypt0afterneoadjuvantchemoradiotherapyncrtfollowedbysurgery
AT yanghaihua prognosticfactorsforsurvivalinesophagealsquamouscellcarcinomaesccpatientswithacompleteregressionoftheprimarytumorypt0afterneoadjuvantchemoradiotherapyncrtfollowedbysurgery
AT chenbaofu prognosticfactorsforsurvivalinesophagealsquamouscellcarcinomaesccpatientswithacompleteregressionoftheprimarytumorypt0afterneoadjuvantchemoradiotherapyncrtfollowedbysurgery
AT zhuchengchu prognosticfactorsforsurvivalinesophagealsquamouscellcarcinomaesccpatientswithacompleteregressionoftheprimarytumorypt0afterneoadjuvantchemoradiotherapyncrtfollowedbysurgery
AT wanggongchao prognosticfactorsforsurvivalinesophagealsquamouscellcarcinomaesccpatientswithacompleteregressionoftheprimarytumorypt0afterneoadjuvantchemoradiotherapyncrtfollowedbysurgery